280 related articles for article (PubMed ID: 11722650)
21. Interleukin-12 but not interleukin-18 is required for immunity to Trypanosoma cruzi in mice.
Graefe SE; Jacobs T; Gaworski I; Klauenberg U; Steeg C; Fleischer B
Microbes Infect; 2003 Aug; 5(10):833-9. PubMed ID: 12919851
[TBL] [Abstract][Full Text] [Related]
22. IFN-gamma, IL-4, IL-10 and IL-12 gene expression in BCG-Leishmania vaccination of Trypanosoma cruzi-infected mice.
Araujo Z; Heremans H; Stordeur P; Wissing M; Goldman M; Castes M; Carlier Y
Vaccine; 2000 Mar; 18(17):1822-9. PubMed ID: 10699330
[TBL] [Abstract][Full Text] [Related]
23. Trypanosoma cruzi: the effect of nitric oxide synthesis inhibition on the CD4 T cell response to the trans-sialidase superfamily.
Millar AE; Kahn SJ
Exp Parasitol; 2000 Feb; 94(2):84-91. PubMed ID: 10673344
[TBL] [Abstract][Full Text] [Related]
24. Protective immunity induced by a Trypanosoma cruzi soluble extract antigen in experimental Chagas' disease. Role of interferon gamma.
Garcia CA; Oliveira EC; Sakurada JK; Santos LM
Immunol Invest; 2000 Feb; 29(1):1-12. PubMed ID: 10709842
[TBL] [Abstract][Full Text] [Related]
25. Trypanosoma cruzi-induced suppression of IL-2 production. I. Evidence for the presence of IL-2-producing cells.
Tarleton RL
J Immunol; 1988 Apr; 140(8):2763-8. PubMed ID: 2965729
[TBL] [Abstract][Full Text] [Related]
26. Roles of gamma interferon and other cytokines in suppression of the spleen cell proliferative response to concanavalin A and toxoplasma antigen during acute toxoplasmosis.
Candolfi E; Hunter CA; Remington JS
Infect Immun; 1995 Mar; 63(3):751-6. PubMed ID: 7868243
[TBL] [Abstract][Full Text] [Related]
27. Differential regulation of lymphoproliferative responses to Trypanosoma cruzi antigen in patients with the cardiac or indeterminate form of Chagas disease.
de Barros-Mazon S; Guariento ME; da Silva CA; Coffman RL; Abrahamsohn IA
Clin Immunol; 2004 Apr; 111(1):137-45. PubMed ID: 15093563
[TBL] [Abstract][Full Text] [Related]
28. Novel mechanism for Trypanosoma cruzi-induced suppression of human lymphocytes. Inhibition of IL-2 receptor expression.
Beltz LA; Sztein MB; Kierszenbaum F
J Immunol; 1988 Jul; 141(1):289-94. PubMed ID: 3132504
[TBL] [Abstract][Full Text] [Related]
29. Role of IFN-alpha/beta and IL-12 in the activation of natural killer cells and interferon-gamma production during experimental infection with Trypanosoma cruzi.
Une C; Andersson J; Orn A
Clin Exp Immunol; 2003 Nov; 134(2):195-201. PubMed ID: 14616777
[TBL] [Abstract][Full Text] [Related]
30. Restoration of in vitro immune responses of spleen cells from mice infected with Trypanosoma cruzi by supernatants containing interleukin 2.
Tarleton RL; Kuhn RE
J Immunol; 1984 Sep; 133(3):1570-5. PubMed ID: 6431001
[TBL] [Abstract][Full Text] [Related]
31. CTLA-4 blockage increases resistance to infection with the intracellular protozoan Trypanosoma cruzi.
Martins GA; Tadokoro CE; Silva RB; Silva JS; Rizzo LV
J Immunol; 2004 Apr; 172(8):4893-901. PubMed ID: 15067068
[TBL] [Abstract][Full Text] [Related]
32. IL-10 participates in the expansion and functional activation of CD8
Pino-Martínez AM; Miranda CG; Batalla EI; González-Cappa SM; Alba Soto CD
J Leukoc Biol; 2019 Jan; 105(1):163-175. PubMed ID: 30371945
[TBL] [Abstract][Full Text] [Related]
33. Modification of T-cell proliferation and interleukin 2 production in mice infected with Trypanosoma cruzi.
Harel-Bellan A; Joskowicz M; Fradelizi D; Eisen H
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3466-9. PubMed ID: 6407015
[TBL] [Abstract][Full Text] [Related]
34. NK1.1+ cells and T-cell activation in euthymic and thymectomized C57Bl/6 mice during acute Trypanosoma cruzi infection.
Cardillo F; Cunha FQ; Tamashiro WM; Russo M; Garcia SB; Mengel J
Scand J Immunol; 2002 Jan; 55(1):96-104. PubMed ID: 11841697
[TBL] [Abstract][Full Text] [Related]
35. Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection.
Reyes JL; Terrazas LI; Espinoza B; Cruz-Robles D; Soto V; Rivera-Montoya I; Gómez-García L; Snider H; Satoskar AR; Rodríguez-Sosa M
Infect Immun; 2006 Jun; 74(6):3170-9. PubMed ID: 16714544
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow-derived macrophages grown in GM-CSF or M-CSF differ in their ability to produce IL-12 and to induce IFN-gamma production after stimulation with Trypanosoma cruzi antigens.
Tadokoro CE; de Almeida Abrahamsohn I
Immunol Lett; 2001 May; 77(1):31-8. PubMed ID: 11348667
[TBL] [Abstract][Full Text] [Related]
37. Does interleukin-2 restore lymphocyte responses suppressed by Trypanosoma cruzi?
Kierszenbaum F; Mejia Lopez H; Sztein MB
Immunology; 1993 Nov; 80(3):445-50. PubMed ID: 8288318
[TBL] [Abstract][Full Text] [Related]
38. Trypanosoma cruzi trans-sialidase potentiates T cell activation through antigen-presenting cells: role of IL-6 and Bruton's tyrosine kinase.
Gao W; Pereira MA
Eur J Immunol; 2001 May; 31(5):1503-12. PubMed ID: 11465107
[TBL] [Abstract][Full Text] [Related]
39. Trypanosoma cruzi: Tc52 released protein-induced increased expression of nitric oxide synthase and nitric oxide production by macrophages.
Fernandez-Gomez R; Esteban S; Gomez-Corvera R; Zoulika K; Ouaissi A
J Immunol; 1998 Apr; 160(7):3471-9. PubMed ID: 9531308
[TBL] [Abstract][Full Text] [Related]
40. Trypanosoma cruzi: analysis of cellular and humoral response against a protective recombinant antigen during experimental Chagas' disease.
Taibi A; Espinoza AG; Ouaissi A
Immunol Lett; 1995 Dec; 48(3):193-200. PubMed ID: 8867851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
